Nifedipine Tablet, Extended Release
Product Images NDC 51655-738

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 51655-738). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 738 52 Master Bottle Label Approval Rev A 06 21)

Label for Nifedipine Extended-release Tablets USP 90 mg in a bottle containing 30 tablets. The label indicates prescription use only, storage instructions to keep between 20° to 25°C (68° to 77°F), and precaution to protect from moisture and humidity. Manufactured and repackaged by Northwind Pharmaceuticals, USA.*

FDA Label Image

Image Description (6d475a6d Figure 01)

Chemical structure diagram of the active ingredient Nifedipine, showing the molecular arrangement of atoms including nitrogen, carbon, oxygen, and associated functional groups distinctive to this compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.